ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 177 filers reported holding ARCUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
| Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
| Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
| Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
| Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
| Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
| Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
| Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $32,741,284 | 17.51% |
| Octagon Capital Advisors LP | 1,968,000 | $39,970,080 | 5.56% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $17,665,435 | 5.54% |
| Logos Global Management LP | 750,000 | $15,232,500 | 2.07% |
| Boxer Capital, LLC | 1,602,200 | $32,541 | 1.51% |
| DAFNA Capital Management LLC | 225,717 | $4,584,312 | 1.25% |
| SECTORAL ASSET MANAGEMENT INC | 354,490 | $7,199,692 | 1.20% |
| PFM Health Sciences, LP | 1,405,056 | $28,536,687 | 1.11% |
| Ikarian Capital, LLC | 280,000 | $5,686,800 | 0.91% |
| Ikarian Capital, LLC | 200,000 | $4,062,000 | 0.65% |